Drug makers spend 6.3% of revenue on R&D in first quarter

Published: 2011-06-10 07:00:00

Updated: 2011-06-10 07:00:00

Details of drug company spending, revealed by Yakup com., showed that the country's 51 pharmaceutical companies on average spent 6.32 percent of their revenue on research and development (R&D) in the first half, much less than the 20 percent overseas pharmaceutical firms spend ― on research and d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK